Business Description
Imunon Inc
NAICS : 325412
SIC : 2834
ISIN : US15117N6022
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.82 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.37 | |||||
Debt-to-EBITDA | -0.07 | |||||
Interest Coverage | N/A | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 39.6 | |||||
3-Year EPS without NRI Growth Rate | 36.6 | |||||
3-Year FCF Growth Rate | 33.6 | |||||
3-Year Book Growth Rate | -40.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 24.49 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.95 | |||||
9-Day RSI | 35.7 | |||||
14-Day RSI | 41.39 | |||||
6-1 Month Momentum % | 49.91 | |||||
12-1 Month Momentum % | 3.87 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.51 | |||||
Quick Ratio | 1.51 | |||||
Cash Ratio | 1.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -51.3 | |||||
Shareholder Yield % | 25.07 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -138.64 | |||||
ROA % | -91.04 | |||||
ROIC % | -657.81 | |||||
3-Year ROIIC % | 16.34 | |||||
ROC (Joel Greenblatt) % | -884.2 | |||||
ROCE % | -137.17 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.59 | |||||
Price-to-Tangible-Book | 2.59 | |||||
EV-to-EBIT | -0.56 | |||||
EV-to-Forward-EBIT | -0.4 | |||||
EV-to-EBITDA | -0.58 | |||||
EV-to-FCF | -0.58 | |||||
Price-to-Net-Current-Asset-Value | 5.61 | |||||
Earnings Yield (Greenblatt) % | -178.57 | |||||
FCF Yield % | -127.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Imunon Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -1.92 | ||
Beta | 1.42 | ||
Volatility % | 153.7 | ||
14-Day RSI | 41.39 | ||
14-Day ATR ($) | 0.077708 | ||
20-Day SMA ($) | 1.1195 | ||
12-1 Month Momentum % | 3.87 | ||
52-Week Range ($) | 0.49428 - 3.634 | ||
Shares Outstanding (Mil) | 14.4 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Imunon Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Imunon Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Imunon Inc Frequently Asked Questions
What is Imunon Inc(LTS:0HUZ)'s stock price today?
When is next earnings date of Imunon Inc(LTS:0HUZ)?
Does Imunon Inc(LTS:0HUZ) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |